-
REAL-WORLD SAFETY OF XANOMELINE/TROSPIUM CHLORIDE IN SCHIZOPHRENIA MANAGEMENT
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF CRS AND ICANS SEVERITY ACROSS SIX COMMERCIAL CAR-T THERAPIES
Mar 18, 2026, 21:38 PM -
MODELLING ASSOCIATIONS BETWEEN EXTREME POVERTY TRAJECTORIES AND POPULATION GROWTH FOR HEALTH SYSTEMS PLANNING
Mar 18, 2026, 21:38 PM -
INFLUENCING FACTORS ON THE APPROVAL LAG FOR INNOVATIVE DRUGS IN CHINA
Mar 18, 2026, 21:38 PM -
ANALYSIS OF HOSPITAL LENGTH OF STAY IN HONG KONG: EFFECTS OF AGE, CONDITIONS, AND COMORBIDITY INTERACTIONS
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ONCOLOGY MEDICINES IN LATIN AMERICA: AVAILABILITY AND TIME-TO-ACCESS ACROSS HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
THE ECONOMIC BENEFIT OF A PRE-FILLED SYRINGE AS A ROUTE OF ADMINISTRATION: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
IMPACT AND COST-EFFECTIVENESS OF DOXYCYCLINE POST-EXPOSURE PROPHYLAXIS IN AUSTRALIAN MEN WHO HAVE SEX WITH MEN
Mar 18, 2026, 21:38 PM -
DEVELOPING AND OPERATIONALIZING A SOCIETAL VALUE FRAMEWORK: A STYLIZED CASE STUDY IN ADVANCED HEPATOCELLULAR CARCINOMA
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND DIRECT MEDICAL COSTS OF CHRONIC URTICARIA IN CHINA: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
OUT-OF-POCKET COST BURDEN AMONG PATIENTS DIAGNOSED WITH BREAST CANCER AND MENTAL HEALTH COMORBIDITIES: A CROSS-SECTIONAL STUDY USING MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA
Mar 18, 2026, 21:38 PM -
FROM PROMPT ENGINEERING TO DECISION-MAKING: ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM -
FAST-TRACKING RARE DISEASES: USE OF FDA EXPEDITED PATHWAYS FOR ORPHAN DRUGS
Mar 18, 2026, 21:38 PM -
MPACT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS TO TREAT OBESITY ON NON-GLP-1 COSTS AMONG COMMERCIALLY INSURED MEMBERS WITHOUT DIABETES: A THREE-YEAR RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
PREOPERATIVE USE OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS)AND SHORT-TERM POSTOPERATIVE OUTCOMES AFTER BARIATRIC SURGERY: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
COMPARING THE DISEASE BURDEN OF MIGRAINE BETWEEN USERS OF CGRP MONOCLONAL ANTIBODIES AND PREVENTIVE GEPANTS
Mar 18, 2026, 21:38 PM -
A NOVEL BAYESIAN MODELING APPROACH INCREASES PRECISION OF PREDICTED LONG-TERM DURABILITY OF ETRANACOGENE DEZAPARVOVEC FOR THE TREATMENT OF HEMOPHILIA B
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC MAPPING OF CANCER INCIDENCE IN DENMARK: IDENTIFYING POTENTIAL FOR DECENTRALIZED ONCOLOGY CARE IN LUNG CANCER CARE (HEATMAP-ONCO-LUNG)
Mar 18, 2026, 21:38 PM -
CAN PUBMED ALONE CAPTURE THE EVIDENCE BASE FOR TARGETED LITERATURE REVIEWS? A CASE STUDY
Mar 18, 2026, 21:38 PM -
ESTIMATING THE FINANCIAL IMPACT OF DUPILUMAB FOR COPD USING REAL-WORLD CLAIMS DATA: A PROBABILISTIC BUDGET IMPACT ANALYSIS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM
